{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:20:48Z","timestamp":1794957648354,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Repetitive nerve stimulation (RNS) is a standard test for the diagnosis of myasthenia gravis (MG), where decrement of compound muscle action potentials (CMAP) corresponds to clinical muscle fatigability. Our aim was to ascertain the diagnostic and prognostic utility of RNS in MG patients. This study included MG patients treated between 01\/2000 and 12\/2016, with an observational period of at least one year and a minimum of two neurological examinations. Clinical and electrophysiological data were retrospectively gathered from patient records, and CMAP decrement was correlated with autoantibody titers and clinical disease severity at different time points. Ninety-four patients were included, with 88.3% of the cohort testing positive for acetylcholine receptor autoantibodies (AChR-Abs). RNS sensitivity was higher in patients with generalized disease (71.6%) than in purely ocular MG (38.5%). CMAP decrement did not significantly correlate with AChR-Ab titers, nor with clinical symptom severity at the time of testing or last follow up. However, there was a significant correlation between CMAP decrement and the worst recorded clinical status on a group level. RNS testing is more sensitive in generalized disease and AChR-Ab positive patients, but our data do not support RNS as a tool for long-term outcome prediction. Future studies with a prospective study design could help to overcome a number of limiting factors discussed in our study.<\/jats:p>","DOI":"10.1038\/s41598-023-30154-5","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T11:03:59Z","timestamp":1676891039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-1178","authenticated-orcid":false,"given":"Matthias","family":"Tomschik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-3716","authenticated-orcid":false,"given":"Fiona","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-5234","authenticated-orcid":false,"given":"Chiara","family":"Paternostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-4572","authenticated-orcid":false,"given":"Jakob","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Rinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-684X","authenticated-orcid":false,"given":"Gudrun","family":"Zulehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-5480","authenticated-orcid":false,"given":"Fritz","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7261","authenticated-orcid":false,"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"30154_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0038-1660500","volume":"38","author":"H Cetin","year":"2018","unstructured":"Cetin, H. & Vincent, A. Pathogenic mechanisms and clinical correlations in autoimmune myasthenic syndromes. Semin. Neurol. 38, 344\u2013354. https:\/\/doi.org\/10.1055\/s-0038-1660500 (2018).","journal-title":"Semin. Neurol."},{"key":"30154_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus, N. E. & Verschuuren, J. J. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet. Neurol. 14, 1023\u20131036. https:\/\/doi.org\/10.1016\/s1474-4422(15)00145-3 (2015).","journal-title":"Lancet. Neurol."},{"key":"30154_CR3","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1212\/WNL.0000000000008688","volume":"94","author":"B Neumann","year":"2020","unstructured":"Neumann, B. et al. Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases. Neurology 94, e299\u2013e313. https:\/\/doi.org\/10.1212\/WNL.0000000000008688 (2020).","journal-title":"Neurology"},{"key":"30154_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-510x(91)90260-e","volume":"106","author":"E Beghi","year":"1991","unstructured":"Beghi, E. et al. Prognosis of myasthenia gravis: A multicenter follow-up study of 844 patients. J. Neurol. Sci. 106, 213\u2013220. https:\/\/doi.org\/10.1016\/0022-510x(91)90260-e (1991).","journal-title":"J. Neurol. Sci."},{"key":"30154_CR5","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/wnl.0000000000008903","volume":"94","author":"E Cort\u00e9s-Vicente","year":"2020","unstructured":"Cort\u00e9s-Vicente, E. et al. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset. Neurology 94, e1171\u2013e1180. https:\/\/doi.org\/10.1212\/wnl.0000000000008903 (2020).","journal-title":"Neurology"},{"key":"30154_CR6","doi-asserted-by":"publisher","first-page":"e1426","DOI":"10.1212\/wnl.0000000000010209","volume":"95","author":"M Tomschik","year":"2020","unstructured":"Tomschik, M. et al. Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis. Neurology 95, e1426\u2013e1436. https:\/\/doi.org\/10.1212\/wnl.0000000000010209 (2020).","journal-title":"Neurology"},{"key":"30154_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/mus.25539","volume":"56","author":"A Abraham","year":"2017","unstructured":"Abraham, A. et al. Electrophysiological testing is correlated with myasthenia gravis severity. Muscle Nerve 56, 445\u2013448. https:\/\/doi.org\/10.1002\/mus.25539 (2017).","journal-title":"Muscle Nerve"},{"key":"30154_CR8","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.clinph.2004.05.024","volume":"115","author":"J Costa","year":"2004","unstructured":"Costa, J., Evangelista, T., Concei\u00e7\u00e3o, I. & de Carvalho, M. Repetitive nerve stimulation in myasthenia gravis\u2013relative sensitivity of different muscles. Clin. Neurophysiol. Off. J. Int. Feder. Clin. Neurophysiol. 115, 2776\u20132782. https:\/\/doi.org\/10.1016\/j.clinph.2004.05.024 (2004).","journal-title":"Clin. Neurophysiol. Off. J. Int. Feder. Clin. Neurophysiol."},{"key":"30154_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3988\/jcn.2021.17.2.265","volume":"17","author":"KH Kim","year":"2021","unstructured":"Kim, K. H., Kim, S. W. & Shin, H. Y. Initial repetitive nerve stimulation test predicts conversion of ocular myasthenia gravis to generalized myasthenia gravis. J. Clin. Neurol. 17, 265\u2013272. https:\/\/doi.org\/10.3988\/jcn.2021.17.2.265 (2021).","journal-title":"J. Clin. Neurol."},{"key":"30154_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders, D. B. et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 87, 419\u2013425. https:\/\/doi.org\/10.1212\/WNL.0000000000002790 (2016).","journal-title":"Neurology"},{"key":"30154_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/mus.25374","volume":"55","author":"H Bou Ali","year":"2017","unstructured":"Bou Ali, H. et al. New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia gravis. Muscle Nerve 55, 532\u2013538. https:\/\/doi.org\/10.1002\/mus.25374 (2017).","journal-title":"Muscle Nerve"},{"key":"30154_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0168-5597(93)90130-h","volume":"89","author":"RP Kennett","year":"1993","unstructured":"Kennett, R. P. & Fawcett, P. R. Repetitive nerve stimulation of anconeus in the assessment of neuromuscular transmission disorders. Electroencephalogr. Clin. Neurophysiol. 89, 170\u2013176. https:\/\/doi.org\/10.1016\/0168-5597(93)90130-h (1993).","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"30154_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/mus.20511","volume":"33","author":"LH Zinman","year":"2006","unstructured":"Zinman, L. H. et al. Sensitivity of repetitive facial-nerve stimulation in patients with myasthenia gravis. Muscle Nerve 33, 694\u2013696. https:\/\/doi.org\/10.1002\/mus.20511 (2006).","journal-title":"Muscle Nerve"},{"key":"30154_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mus.20498","volume":"33","author":"SJ Oh","year":"2006","unstructured":"Oh, S. J. et al. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve 33, 500\u2013504. https:\/\/doi.org\/10.1002\/mus.20498 (2006).","journal-title":"Muscle Nerve"},{"key":"30154_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","volume":"16","author":"M Benatar","year":"2006","unstructured":"Benatar, M. A systematic review of diagnostic studies in myasthenia gravis. Neuromus. Disord. NMD 16, 459\u2013467. https:\/\/doi.org\/10.1016\/j.nmd.2006.05.006 (2006).","journal-title":"Neuromus. Disord. NMD"},{"key":"30154_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000324915","volume":"65","author":"T Zambelis","year":"2011","unstructured":"Zambelis, T., Kokotis, P. & Karandreas, N. Repetitive nerve stimulation of facial and hypothenar muscles: Relative sensitivity in different myasthenia gravis subgroups. Eur. Neurol. 65, 203\u2013207. https:\/\/doi.org\/10.1159\/000324915 (2011).","journal-title":"Eur. Neurol."},{"key":"30154_CR17","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.clinph.2005.05.017","volume":"116","author":"A Rostedt","year":"2005","unstructured":"Rostedt, A., Padua, L. & St\u00e5lberg, E. V. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients. Clin. Neurophysiol. Off. J. Int. Feder. Clin. Neurophysiol. 116, 2058\u20132064. https:\/\/doi.org\/10.1016\/j.clinph.2005.05.017 (2005).","journal-title":"Clin. Neurophysiol. Off. J. Int. Feder. Clin. Neurophysiol."},{"key":"30154_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","volume":"13","author":"C Barnett","year":"2012","unstructured":"Barnett, C., Katzberg, H., Nabavi, M. & Bril, V. The quantitative myasthenia gravis score: Comparison with clinical, electrophysiological, and laboratory markers. J. Clin. Neuromuscul. Dis. 13, 201\u2013205. https:\/\/doi.org\/10.1097\/CND.0b013e31824619d5 (2012).","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"30154_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/mus.20908","volume":"37","author":"L Zinman","year":"2008","unstructured":"Zinman, L., Baryshnik, D. & Bril, V. Surrogate therapeutic outcome measures in patients with myasthenia gravis. Muscle Nerve 37, 172\u2013176. https:\/\/doi.org\/10.1002\/mus.20908 (2008).","journal-title":"Muscle Nerve"},{"key":"30154_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mus.25440","volume":"56","author":"DB Sanders","year":"2017","unstructured":"Sanders, D. B. & Massey, J. M. Does change in neuromuscular jitter predict or correlate with clinical change in MG?. Muscle Nerve 56, 45\u201350. https:\/\/doi.org\/10.1002\/mus.25440 (2017).","journal-title":"Muscle Nerve"},{"key":"30154_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.expneurol.2015.01.011","volume":"270","author":"PM Rodriguez Cruz","year":"2015","unstructured":"Rodriguez Cruz, P. M., Huda, S., Lopez-Ruiz, P. & Vincent, A. Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases. Exp. Neurol. 270, 66\u201371. https:\/\/doi.org\/10.1016\/j.expneurol.2015.01.011 (2015).","journal-title":"Exp. Neurol."},{"key":"30154_CR22","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/NXI.0000000000000357","volume":"4","author":"S Huda","year":"2017","unstructured":"Huda, S. et al. IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG. Neurol. Neuroimmunol. Neuroinflamm. 4, e357. https:\/\/doi.org\/10.1212\/NXI.0000000000000357 (2017).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30154-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T11:05:51Z","timestamp":1676891151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30154"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30154-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"20 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2985"}}